Press release
2023-05-11
ImmuneBiotech Medical Sweden AB announces the appointment of international microbiome expert Kristin Wannerberger to board of directors2021-01-20
ImmuneBiotech closes fully subscribed new share issue with funding from recognized investors and existing shareholders2020-09-22
ImmuneBiotech: Patent granted for GutMagnific® in the United States2020-06-10
ImmuneBiotech: starts clinical trial of GutMagnific® in ME/CFS in collaboration with Stora Sköndal ME clinic2019-10-16
ImmuneBiotech: market launch of first product GutMagnific2019-05-07
ImmuneBiotech: Winner of H2020 “SME Instrument” Phase 12019-01-24
ImmuneBiotech closes new share issue with funding from recognized international investors and business angels
News
November, 2023
ImmuneBiotech’s 10th anniversaryNovember, 2023
Our CEO Dr Shahram Lavasani is currently in the USA at the Microbiome Movement-Human Nutrition conference.November, 2023
Our CEO Shahram Lavasani was invited keynote speaker at Plovdiv University (Bulgaria) at the “Biotechnologies for Personalized Medicine” conference.November, 2023
Our 10-year anniversary is approaching!October, 2023
ImmuneBiotech featured in Dagens Nyheter (Sweden’s leading newspaper) October 16October, 2023
We´ll be talking at Malmö´s Rotary Club on the 9 th of October with a presentation on: Precision Probiotics: Your Path to Personalized HealthSeptember, 2023
Meet us at the Swedish-Danish Life Science Conference 2023September, 2023
Meet us in Rome at the 12th Probiotics, Prebiotics & New Foods conference in Rome
Press contact
For media inquiries, please write to info@immunebiotech.com
ImmuneBiotech AB
Scheelevägen 2, Medicon Village
223 81 Lund, Sweden
Phone: +46 46 25 25 50
GutMagnific Web Shop: www.GutMagnific.com
Follow us on LinkedIn for the latest updates and information.